Wealth Architects’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
PA
NHAS
BTW
Wealth Architects's CORT Position: Q2 2023 in Review
Wealth Architects sold out of Corcept Therapeutics (CORT) in Q2 2023, closing a stake of 9,828 shares — an estimated $213K sold.
Wealth Architects first reported a position in CORT in Q2 2016 and held it in 23 quarters. The position peaked at $324K in Q4 2020. 224 funds tracked by Wall St. Rank hold CORT as of Q2 2023.
- Wealth Architects reported no remaining Corcept Therapeutics position as of Q2 2023 after selling out during the quarter.
- Wealth Architects sold 9,828 Corcept Therapeutics shares in Q2 2023, an estimated $213K.
- Wealth Architects first reported a position in Corcept Therapeutics in Q2 2016 and held it in 23 quarters.
- Wealth Architects's Corcept Therapeutics position peaked at $324K in Q4 2020.
- 224 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2023.
Based on Wealth Architects's 13F filing for Q2 2023, filed 2 Aug 2023.